Yervoi 50mg Injection contains Ipilimumab, a monoclonal antibody that improves the immune system’s ability to target and destroy cancer cells.
Tell your doctor about any liver problems, organ transplants, immune system disorders, and any drugs or supplements you use before starting Yervoi 50mg. Use effective contraception during treatment and for three months following the last dose, and refrain from using it while pregnant or nursing.
Yervoi 50mg Injection contains Ipilimumab, a monoclonal antibody that improves the immune system’s ability to target and destroy cancer cells.
Brand Name: Yervoi
Composition: Ipilimumab
Mechanism of Action:
Ipilimumab inhibits the receptor known as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which suppresses T-cell activation. It increases T-cell activity by blocking CTLA-4, which encourages an immune-mediated assault on cancer cells.
Uses:
Melanoma
Dosage and Administration:
Intravenous infusion is the method of administration. For melanoma, 3 mg/kg is usually given every three weeks for a total of four treatments. Depending on the indication or combination therapy, different dose changes may be necessary.
Side Effects:
Safety Advise:
Lungs 
The safety of Yervoi for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.
Liver
The safety of Yervoi for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.
Kidney
The safety of Yervoi for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.
Pregnancy
Yervoi should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.
Breast Feeding
Using Yervoi while nursing is most likely dangerous. Kindly speak with your healthcare provider.
Storage:
Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
How to use this Medication?
An intravenous injection of ipilimumab is given by a physician or nurse. It is administered for ninety minutes every three weeks (four doses) and then every twelve weeks to prevent melanoma. As directed by your physician, it is administered either by alone or in combination with nivolumab for 30 minutes every three or six weeks to treat melanoma, kidney, hepatic, colorectal, or other malignancies.
You will be closely watched both during and after the infusion because ipilimumab might induce dangerous infusion reactions. Inform your doctor right once if you experience any of the following symptoms: fever, chills, rash, flushing, breathing difficulties, or dizziness.
Disclaimer:
The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.
Marketer details
Name: Bristol Myers Squibb
Address: Bristol Myers Squibb Corporate Headquarters 430 E. 29th Street, 14th Floor, New York, NY 10016
Country of origin: India
We deliver within Bangalore city limits in 24 hours for orders above ₹10,000, with exceptions based on location, while other deliveries rely on trusted courier partners and their timelines.
We provide only authentic, verified medicines sourced from manufacturers or authorized distributors, ensuring proper cold chain storage throughout delivery.
We are available around the clock to assist you.
Shop with confidence, knowing your data is safe with us.
